U. Germing

Type de document

Articles (5)

Co-auteur

Date

Source

Mot-clé

survie (4) Survival (4) Patients (4) Human beings (4) Patients (4) temps (durée) (3) risque (3) taux (3) Myelodysplastic syndromes (3) Time (3) Risk (3) Prognosis (3) Older people (3) Prognosis (3) leucémie (2) âge (2) adulte (2) Diagnosis (2) Treatment (2) Acute myeloid leukemia (2) Value (2) Relevance (2) Multivariate analysis (2) Months (2) Bone marrow (2) Leukemia (2) Impact (2) Diagnosis (2) Blood platelets (2) Blood (2)

Documents écrit par U. Germing (5) | parle de U. Germing (0)

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.
A. Kuendgen et al.
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
T. Silzle et al. (9 août 2019)
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.
M. Mallo et al. (2011)
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
J. Neukirchen et al.
Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement
S. Knipp et al.